| miR-214 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
18199536 |
|
| miR-34 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
18803879 |
|
| let-7e |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-010a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-016b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-019b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-020 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-023a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-023b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-026a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-029c |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-092 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-093 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-099 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-100 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-106a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
18823650 |
|
| miR-106a |
Cisplatin |
ovarian cancer |
Resistant |
High |
18823650 |
|
| let-7i |
Cisplatin |
ovarian and breast cancer |
Sensitive |
Low |
19074899 |
|
| miR-126 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
19074899 |
|
| miR-152 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-196a |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-198 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-1b-1 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-214 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-216 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-22 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-223 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-321* |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-370 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-509 |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-520e |
Cisplatin |
ovarian cancer |
Resistant |
High |
19074899 |
|
| miR-521 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
19074899 |
|
| miR-21 |
Cisplatin |
breast cancer |
Resistant |
Low |
19082437 |
|
| miR-518 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
19237188 |
|
| miR-518c-AS |
Cisplatin |
ovarian cancer |
Sensitive |
High |
19237188 |
|
| miR-520f |
Cisplatin |
ovarian cancer |
Sensitive |
High |
19237188 |
|
| miR-520f |
Cisplatin |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-99b |
Cisplatin |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-27a |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
Low |
19960259 |
|
| miR-10a |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-10b |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-126 |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-127 |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-132 |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-141 |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-146a |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-194 |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-196 |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-200b |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-200c |
Cisplatin |
breast cancer |
Resistant |
High |
20099276 |
|
| miR-205 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-206 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-214 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-221 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-222 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-29a |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-29b |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-342 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-345 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-429 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-489 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-7 |
Cisplatin |
breast cancer |
Sensitive |
High |
20099276 |
|
| miR-181b |
Cisplatin |
lung cancer |
Sensitive |
Low |
20162574 |
|
| let-7c |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| let-7d |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| let-7e |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| let-7g |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-181d |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-188 |
Cisplatin |
tongue squamous cell carcinoma |
Sensitive |
High |
20219416 |
|
| miR-20b |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-21 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-214 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-23a |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-30d |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-342 |
Cisplatin |
tongue squamous cell carcinoma |
Sensitive |
High |
20219416 |
|
| miR-373* |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-432 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-498 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-518c* |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-584 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-608 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-628 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
High |
20219416 |
|
| miR-296 |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
Low |
20485139 |
|
| miR-92a-2* |
Cisplatin |
small cell lung cancer |
Resistant |
Low |
20548249 |
|
| miR-186* |
Cisplatin |
lung adenocarcinoma |
Resistant |
Low |
20627087 |
|
| miR-186* |
Cisplatin |
lung carcinoma |
Resistant |
Low |
20677554 |
|
| miR-200c |
Cisplatin |
non-small cell lung cancer |
Sensitive |
Low |
20696752 |
|
| miR-106b |
Cisplatin |
testicular cancer |
Associated |
Low |
20811155 |
|
| miR-200c |
Cisplatin |
gastric cancer |
Sensitive |
Low |
21114921 |
|
| miR-34a |
Cisplatin |
medulloblastoma |
Sensitive |
Low |
21177782 |
|
| miR-376c |
Cisplatin |
ovarian cancer |
Resistant |
Low |
21224400 |
|
| miR-148a |
Cisplatin |
adenocarcinoma |
Sensitive |
Low |
21246413 |
|
| miR-148a |
Cisplatin |
squamous cell carcinoma |
Sensitive |
Low |
21246413 |
|
| miR-145 |
Cisplatin |
esophageal cancer |
Resistant |
High |
21248297 |
|
| miR-200c |
Cisplatin |
esophageal cancer |
Resistant |
Low |
21248297 |
|
| miR-21 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
21248297 |
|
| miR-497 |
Cisplatin |
gastric cancer and lung cancer |
Sensitive |
Low |
21258880 |
|
| miR-497 |
Cisplatin |
lung cancer |
Sensitive |
Low |
21258880 |
|
| miR-141 |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
Low |
21289630 |
|
| miR-19a |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
21289630 |
|
| miR-19b |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
21289630 |
|
| miR-200a |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
21289630 |
|
| miR-205 |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
21289630 |
|
| miR-20a |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
21289630 |
|
| miR-20b |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
21289630 |
|
| miR-21 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
21289630 |
|
| miR-27a |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
21289630 |
|
| miR-193a |
Cisplatin |
squamous cell carcinoma |
Resistant |
Low |
21293058 |
|
| miR-451 |
Cisplatin |
non-small cell lung cancer |
Sensitive |
Low |
21329503 |
|
| miR-205 |
Cisplatin |
prostate cancer |
Sensitive |
Low |
21368878 |
|
| miR-31 |
Cisplatin |
prostate cancer |
Sensitive |
Low |
21368878 |
|
| miR-141 |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
Low |
21390040 |
|
| miR-27a |
Cisplatin |
gastric cancer |
Resistant |
Low |
21569481 |
|
| miR-100 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-10b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-10b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-125b |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-125b |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-130b |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-145 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-146 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-146a |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-192 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-193a |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-193b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-194 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-19b-1 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-205 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-205 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-21 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-218 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-218 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-221 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-296 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-302a |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-302b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-302b |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-302d |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-335 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-335* |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-34a |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-362 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-362 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-363 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-365 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-371 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-372 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-373 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-383 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-424 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-450b |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-455 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-484 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-489 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-512 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-512 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-515 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-516b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-517a |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-517b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-517c |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-518a |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-518b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-518c |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-518d |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-518e |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-518f |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-519a |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-519b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-519c |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-519d |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-520b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-520c |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-520f |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-520g |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-520h |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-522 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-523 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-524 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-525 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-526 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-526b |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-576 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-582 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-708 |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-801 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-923 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-935 |
Cisplatin |
germ cell tumor |
Resistant |
High |
21575166 |
|
| miR-99a |
Cisplatin |
germ cell tumor |
Sensitive |
High |
21575166 |
|
| miR-21 |
Cisplatin |
head and neck squamous cell carcinoma |
Sensitive |
Low |
21685938 |
|
| miR-34a |
Cisplatin |
bladder cancer |
Sensitive |
Low |
21702042 |
|
| miR-15b |
Cisplatin |
tongue cancer |
Sensitive |
Low |
21725369 |
|
| miR-200b |
Cisplatin |
tongue cancer |
Sensitive |
Low |
21725369 |
|
| let-7d |
Cisplatin |
oral cancer |
Sensitive |
Low |
21725603 |
|
| miR-122 |
Cisplatin |
hepatocellular carcinoma |
Sensitive |
Low |
21750653 |
|
| miR-1228* |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-1246 |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-138 |
Cisplatin |
non-small cell lung cancer |
Sensitive |
Low |
21787234 |
|
| miR-1470 |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-149* |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-181a |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-1908 |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-194 |
Cisplatin |
Non-small Cell Lung Cancer |
Sensitive |
High |
21787234 |
|
| miR-224 |
Cisplatin |
Non-small Cell Lung Cancer |
Sensitive |
High |
21787234 |
|
| miR-27b |
Cisplatin |
Non-small Cell Lung Cancer |
Sensitive |
High |
21787234 |
|
| miR-34a |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-638 |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-663 |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
21787234 |
|
| miR-886 |
Cisplatin |
Non-small Cell Lung Cancer |
Sensitive |
High |
21787234 |
|
| miR-125b |
Cisplatin |
ovarian cancer |
Resistant |
Low |
21823019 |
|
| miR-125b |
Cisplatin |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-135b |
Cisplatin |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-141 |
Cisplatin |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-182 |
Cisplatin |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-183 |
Cisplatin |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-200b |
Cisplatin |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-210 |
Cisplatin |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-27b |
Cisplatin |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-30b |
Cisplatin |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-30d |
Cisplatin |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-429 |
Cisplatin |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-881* |
Cisplatin |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-96 |
Cisplatin |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| let-7c |
Cisplatin |
ovarian cancer |
Resistant |
High |
21939554 |
|
| miR-1299 |
Cisplatin |
ovarian cancer |
Resistant |
High |
21939554 |
|
| miR-193b |
Cisplatin |
ovarian cancer |
Resistant |
High |
21939554 |
|
| miR-20b |
Cisplatin |
ovarian cancer |
Resistant |
High |
21939554 |
|
| miR-300 |
Cisplatin |
ovarian cancer |
Resistant |
High |
21939554 |
|
| miR-542 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
21939554 |
|
| miR-625 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
21939554 |
|
| miR-642 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
21939554 |
|
| miRplus-F1064 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
21939554 |
|
| miRPlus-F1147 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
21939554 |
|
| miRPlus-F1231 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
21939554 |
|
| miR-200b |
Cisplatin |
lung cancer |
Sensitive |
Low |
21993663 |
|
| miR-200c |
Cisplatin |
lung cancer |
Sensitive |
Low |
21993663 |
|
| miR-429 |
Cisplatin |
lung cancer |
Sensitive |
Low |
21993663 |
|
| miR-130b |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
22005523 |
|
| miR-200c |
Cisplatin |
endometrial carcinoma |
Resistant |
Low |
22015043 |
|
| miR-145 |
Cisplatin |
glioblastoma |
Sensitive |
Low |
22098779 |
|
| miR-363* |
Cisplatin |
gastric cancer |
Resistant |
High |
22112324 |
|
| miR-517* |
Cisplatin |
gastric cancer |
Sensitive |
High |
22112324 |
|
| miR-518f* |
Cisplatin |
gastric cancer |
Resistant |
High |
22112324 |
|
| miR-519e* |
Cisplatin |
gastric cancer |
Resistant |
High |
22112324 |
|
| miR-520a |
Cisplatin |
gastric cancer |
Resistant |
High |
22112324 |
|
| miR-520d* |
Cisplatin |
gastric cancer |
Resistant |
High |
22112324 |
|
| miR-30a |
Cisplatin |
- |
Sensitive |
Low |
22157765 |
|
| miR-128-2 |
Cisplatin |
non-small-cell lung cancer |
Resistant |
Low |
22193543 |
|
| miR-200b |
Cisplatin |
- |
Associated |
Low |
22194984 |
|
| miR-200c |
Cisplatin |
- |
Associated |
Low |
22194984 |
|
| miR-429 |
Cisplatin |
- |
Associated |
Low |
22194984 |
|
| miR-203 |
Cisplatin |
breast cancer |
Resistant |
Low |
22207897 |
|
| miR-21 |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
22237007 |
|
| miR-21 |
Cisplatin |
oral squamous cell carcinoma |
Resistant |
Low |
22249446 |
|
| miR-130a |
Cisplatin |
ovarian cancer |
Associated |
Low |
22455133 |
|
| miR-93 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
22465665 |
|
| miR-199a |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
22498306 |
|
| let-7c |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| let-7d |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| let-7e |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| let-7f |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| let-7g |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| let-7i |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-106a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-106b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-1290 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-130a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-130a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
22614869 |
|
| miR-133b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-148b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-15a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-15b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-16 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-17 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-181d |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-19a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-20a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-20b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-22 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-221 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-222 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-224 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-23a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-25 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-26b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-27a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-29a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-29b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-30b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-30e |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-3175 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-320a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-320d |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-320e |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-331 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-3607 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-365 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-3651 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-3653 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-374a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-374b |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-378 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-423 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-4284 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-4289 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-744 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-92a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-98 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-99a |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miRPlus-A1015 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miRPlus-C1110 |
Cisplatin |
ovarian cancer |
Resistant |
High |
22614869 |
|
| miR-497 |
Cisplatin |
colorectal cancer |
Sensitive |
Low |
22710713 |
|
| miR-199a |
Cisplatin |
hepatocellular carcinoma |
Sensitive |
Low |
22713463 |
|
| miR-513a |
Cisplatin |
lung adenocarcinoma |
Sensitive |
Low |
22749944 |
|
| miR-193b |
Cisplatin |
cancer |
Associated |
Low |
22752226 |
|
| miR-96 |
Cisplatin |
cancer |
Sensitive |
Low |
22761336 |
|
| miR-130a |
Cisplatin |
hepatocellular carcinoma |
Resistant |
Low |
22846564 |
|
| miR-302 |
Cisplatin |
head and neck squamous cell carcinoma |
Resistant |
Low |
22847005 |
|
| let-7b |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
22847808 |
|
| let-7c |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
22847808 |
|
| miR-101 |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
22847808 |
|
| miR-10a |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
22847808 |
|
| miR-135a |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
22847808 |
|
| miR-136 |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
22847808 |
|
| miR-141 |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
22847808 |
|
| miR-145 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-146a |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-202 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-204 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-489 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-545 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-96 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-99a |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
22847808 |
|
| miR-205 |
Cisplatin |
- |
Resistant |
Low |
22871739 |
|
| miR-24 |
Cisplatin |
neuroblastoma |
Sensitive |
Low |
22892391 |
|
| miR-15b |
Cisplatin |
cervical cancer |
Associated |
Low |
22920753 |
|
| miR-16 |
Cisplatin |
cervical cancer |
Associated |
Low |
22920753 |
|
| miR-15 |
Cisplatin |
epidermoid carcinoma, |
Sensitive |
Low |
22942255 |
|
| miR-155 |
Cisplatin |
epidermoid carcinoma, |
Sensitive |
Low |
22942255 |
|
| miR-16 |
Cisplatin |
epidermoid carcinoma, |
Sensitive |
Low |
22942255 |
|
| miR-195 |
Cisplatin |
epidermoid carcinoma, |
Sensitive |
Low |
22942255 |
|
| miR-424 |
Cisplatin |
epidermoid carcinoma, |
Sensitive |
Low |
22942255 |
|
| miR-497 |
Cisplatin |
epidermoid carcinoma, |
Sensitive |
Low |
22942255 |
|
| miR-127 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-142 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-193a |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-218 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-24 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-27a |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-296 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-492 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-576 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-625 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-639 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-642 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-886 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-923 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-944 |
Cisplatin |
Bladder Carcinoma |
Sensitive |
High |
22954303 |
|
| miR-21 |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
22956424 |
|
| miR-200c |
Cisplatin |
melanoma |
Sensitive |
Low |
22982443 |
|
| miR-155 |
Cisplatin |
lung cancer |
Resistant |
Low |
22996741 |
|
| miR-34a |
Cisplatin |
lung cancer |
Sensitive |
Low |
23036084 |
|
| miR-155 |
Cisplatin |
colon cancer |
Resistant |
Low |
23036199 |
|
| miR-100 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-10b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-130a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-135b* |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-141 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
23045278 |
|
| miR-17 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-186* |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-18b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-196a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-199a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-199b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-19a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-19b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-200c |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-20b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-214 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-215 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-222 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-335 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-338 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-412 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-421 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-493* |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-518e |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-631 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-645 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-942 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
23045278 |
|
| miR-21 |
Cisplatin |
neuroblastoma |
Resistant |
Low |
23084187 |
|
| miR-181a |
Cisplatin |
adenocarcinoma |
Resistant |
Low |
23137650 |
|
| miR-181a |
Cisplatin |
lung cancer |
Resistant |
Low |
23137650 |
|
| miR-181a* |
Cisplatin |
adenocarcinoma |
Resistant |
Low |
23137650 |
|
| miR-181a* |
Cisplatin |
lung cancer |
Resistant |
Low |
23137650 |
|
| miR-181b |
Cisplatin |
adenocarcinoma |
Resistant |
Low |
23137650 |
|
| miR-181b |
Cisplatin |
lung cancer |
Resistant |
Low |
23137650 |
|
| miR-29c |
Cisplatin |
nasopharyngeal carcinoma |
Sensitive |
Low |
23142283 |
|
| miR-146a |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-146b |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-181a |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-181d |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-186* |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-1908 |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-1915 |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-193b* |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-194 |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-22 |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-23a |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-26b |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-27b |
Cisplatin |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-300 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-30b |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-30c |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-3183 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-4258 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-4285 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-4311 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-485 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-584 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-612 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-630 |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-99b* |
Cisplatin |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-155 |
Cisplatin |
caski cervical cancer |
Sensitive |
Low |
23284982 |
|
| miR-152 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
23318422 |
|
| miR-185 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
23318422 |
|
| miR-214 |
Cisplatin |
cervical cancer |
Sensitive |
Low |
23337879 |
|
| miR-221 |
Cisplatin |
osteosarcoma |
Resistant |
Low |
23372675 |
|
| miR-218 |
Cisplatin |
cervical cancer |
Sensitive |
Low |
23443110 |
|
| miR-205 |
Cisplatin |
melanoma |
Sensitive |
Low |
23447575 |
|
| miR-21 |
Cisplatin |
gastric cancer |
Resistant |
Low |
23466500 |
|
| miR-10b |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
23484053 |
|
| miR-1224 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-1229 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-1238 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-1273d |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-129 |
Cisplatin |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-133b |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-190 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-197 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-210 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-22 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-31 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-3131 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-3149 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-3162 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-32 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-4701 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-4728 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-4763 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-486 |
Cisplatin |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-501 |
Cisplatin |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-5096 |
Cisplatin |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-532 |
Cisplatin |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-615 |
Cisplatin |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-766 |
Cisplatin |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-877 |
Cisplatin |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-146a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
23554878 |
|
| miR-150 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
23554878 |
|
| miR-223 |
Cisplatin |
breast cancer |
Sensitive |
Low |
23584479 |
|
| miR-223 |
Cisplatin |
colon cancer |
Sensitive |
Low |
23584479 |
|
| miR-302a |
Cisplatin |
testicular embryonal carcinoma |
Sensitive |
Low |
23625774 |
|
| miR-135a |
Cisplatin |
lung cancer |
Sensitive |
Low |
23640248 |
|
| miR-135b |
Cisplatin |
lung cancer |
Sensitive |
Low |
23640248 |
|
| miR-10a* |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-125a |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-132* |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-136 |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-147 |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-155* |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-181d |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-183 |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-186* |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-195* |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-198 |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-320 |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-374a |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-375 |
Cisplatin |
lung adenocarcinoma |
Resistant |
High |
23700794 |
|
| miR-518c* |
Cisplatin |
lung adenocarcinoma |
Sensitive |
High |
23700794 |
|
| miR-541* |
Cisplatin |
lung adenocarcinoma |
Resistant |
High |
23700794 |
|
| miR-551b* |
Cisplatin |
lung adenocarcinoma |
Resistant |
High |
23700794 |
|
| miR-601 |
Cisplatin |
lung adenocarcinoma |
Resistant |
High |
23700794 |
|
| miR-876 |
Cisplatin |
lung adenocarcinoma |
Resistant |
High |
23700794 |
|
| miR-886 |
Cisplatin |
lung adenocarcinoma |
Resistant |
High |
23700794 |
|
| miR-98 |
Cisplatin |
lung adenocarcinoma |
Sensitive |
Low |
23700794 |
|
| miR-223 |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
Low |
23757351 |
|
| miR-10b* |
Cisplatin |
laryngeal cancer |
Sensitive |
High |
23780424 |
|
| miR-25* |
Cisplatin |
laryngeal cancer |
Resistant |
High |
23780424 |
|
| miR-424* |
Cisplatin |
laryngeal cancer |
Resistant |
High |
23780424 |
|
| miR-494 |
Cisplatin |
laryngeal cancer |
Sensitive |
High |
23780424 |
|
| miR-923 |
Cisplatin |
laryngeal cancer |
Sensitive |
High |
23780424 |
|
| miR-93 |
Cisplatin |
laryngeal cancer |
Sensitive |
High |
23780424 |
|
| miR-93* |
Cisplatin |
laryngeal cancer |
Sensitive |
High |
23780424 |
|
| let-7b |
Cisplatin |
glioblastoma |
Sensitive |
Low |
23806108 |
|
| miR-200c |
Cisplatin |
gastric cancer |
Sensitive |
Low |
23821457 |
|
| miR-21 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
23824073 |
|
| miR-101 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-146b |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-148a |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-155 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-181a |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-183 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-185 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-18a |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-194 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-199b |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-203a |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-206 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-214 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-22 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-221 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-25 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-27a |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-296 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-297 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-29c |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-339 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-34c |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-362 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-374a |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-382 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-429 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-429 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-455 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-485 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-485 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-519a |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-574 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-603 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-610 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-630 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-637 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-659 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-7 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-760 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-885 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-920 |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-92b |
Cisplatin |
squamous cell carcinoma |
Sensitive |
High |
23831023 |
|
| miR-98 |
Cisplatin |
squamous cell carcinoma |
Resistant |
High |
23831023 |
|
| miR-503 |
Cisplatin |
non-small cell lung cancer |
Sensitive |
Low |
23856992 |
|
| miR-508 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
23893241 |
|
| miR-29 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
23904094 |
|
| miR-106a |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
23904379 |
|
| miR-20a |
Cisplatin |
gastric cancer |
Resistant |
Low |
23924943 |
|
| miR-153 |
Cisplatin |
colorectal cancer |
Resistant |
Low |
23950211 |
|
| miR-133a |
Cisplatin |
breast cancer |
Sensitive |
Low |
23969999 |
|
| miR-495 |
Cisplatin |
non-small cell lung cancer |
Sensitive |
Low |
24038379 |
|
| miR-10a |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
24040438 |
|
| miR-375 |
Cisplatin |
Non-small Cell Lung Cancer |
Resistant |
High |
24040438 |
|
| miR-34a |
Cisplatin |
gastric cancer |
Sensitive |
Low |
24068565 |
|
| miR-205 |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
24084898 |
|
| miR-103 |
Cisplatin |
- |
Sensitive |
Low |
24088786 |
|
| miR-107 |
Cisplatin |
- |
Sensitive |
Low |
24088786 |
|
| miR-92b |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
24099768 |
|
| miR-31 |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
24099915 |
|
| let-7e |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
24100610 |
|
| miR-187 |
Cisplatin |
peripheral T-cell lymphoma |
Resistant |
Low |
24104394 |
|
| miR-106a |
Cisplatin |
gastric cancer |
Resistant |
Low |
24108762 |
|
| miR-130a |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
24145606 |
|
| miR-181a |
Cisplatin |
tongue squamous cell carcinoma |
Sensitive |
Low |
24148247 |
|
| miR-9 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
24168967 |
|
| miR-181a |
Cisplatin |
cervical squamous cell carcinoma |
Resistant |
Low |
24183997 |
|
| miR-21 |
Cisplatin |
nasopharyngeal carcinoma |
Resistant |
Low |
24194922 |
|
| miR-29a |
Cisplatin |
oral squamous cell carcinoma |
Sensitive |
Low |
24210072 |
|
| miR-328 |
Cisplatin |
colorectal cancer |
Sensitive |
Low |
24318997 |
|
| miR-30d |
Cisplatin |
anaplastic thyroid carcinoma |
Sensitive |
Low |
24345332 |
|
| miR-106a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
24348845 |
|
| miR-205 |
Cisplatin |
prostate cancer |
Sensitive |
Low |
24370341 |
|
| miR-181a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
24394555 |
|
| miR-503 |
Cisplatin |
lung cancer |
Sensitive |
Low |
24398307 |
|
| let-7c |
Cisplatin |
non-small cell lung cancer |
Sensitive |
Low |
24400442 |
|
| miR-137 |
Cisplatin |
small cell lung cancer |
Sensitive |
Low |
24412084 |
|
| miR-34a |
Cisplatin |
bladder cancer |
Sensitive |
Low |
24423412 |
|
| miR-146a |
Cisplatin |
lung cancer |
Sensitive |
Low |
24425875 |
|
| miR-182 |
Cisplatin |
hepatocellular carcinoma |
Resistant |
Low |
24447717 |
|
| miR-16 |
Cisplatin |
lung adenocarcinoma |
Sensitive |
Low |
24462518 |
|
| miR-183 |
Cisplatin |
breast cancer |
Sensitive |
Low |
24462518 |
|
| miR-193a |
Cisplatin |
breast cancer |
Resistant |
Low |
24462518 |
|
| miR-296 |
Cisplatin |
breast cancer |
Resistant |
Low |
24462518 |
|
| miR-33a |
Cisplatin |
osteosarcoma |
Resistant |
Low |
24468065 |
|
| miR-21 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
24472409 |
|
| miR-503 |
Cisplatin |
non-small cell lung cancer |
Associated |
Low |
24486548 |
|
| miR-130a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
24490491 |
|
| miR-27a |
Cisplatin |
bladder cancer |
Sensitive |
Low |
24516043 |
|
| miR-100 |
Cisplatin |
small cell lung cancer |
Resistant |
Low |
24559685 |
|
| miR-100 |
Cisplatin |
chondrosarcoma |
Sensitive |
Low |
24568519 |
|
| let-7c |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-100 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-100* |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-10a |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-125b |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-133a |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-139 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24589211 |
|
| miR-181c* |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-27b |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-33a* |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-34a |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-383 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24589211 |
|
| miR-486 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24589211 |
|
| miR-22 |
Cisplatin |
osteosarcoma |
Sensitive |
Low |
24609901 |
|
| miR-21 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
Low |
24609942 |
|
| miR-141 |
Cisplatin |
gastric cancer |
Resistant |
Low |
24628843 |
|
| let-7a |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| let-7b |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| let-7d |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| let-7f |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| let-7g |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-10b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-1275 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-138 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-141 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-199a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-199b |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
24659709 |
|
| miR-200a |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-200c |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-205 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-21 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-221 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-222 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-23a |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-27a |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-31 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-363 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-452 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-542 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-675 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-886 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-98 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-99a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-Plus B1114 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-Plus C1115 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
24659709 |
|
| miR-PlusA1087 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-PlusC1049 |
Cisplatin |
ovarian cancer |
Resistant |
High |
24659709 |
|
| miR-940 |
Cisplatin |
lung cancer |
- |
Low |
24675421 |
|
| miR-489 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
24686007 |
|
| miR-17 |
Cisplatin |
non-small-cell lung cancer |
Sensitive |
Low |
24722426 |
|
| miR-20a |
Cisplatin |
non-small-cell lung cancer |
Sensitive |
Low |
24722426 |
|
| miR-20b |
Cisplatin |
non-small-cell lung cancer |
Sensitive |
Low |
24722426 |
|
| miR-185 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
24763054 |
|
| miR-200b |
Cisplatin |
small cell lung cancer |
Sensitive |
Low |
24769353 |
|
| miR-34c |
Cisplatin |
osteosarcoma |
Sensitive |
Low |
24802328 |
|
| miR-429 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
24802724 |
|
| miR-192 |
Cisplatin |
lung cancer |
Resistant |
Low |
24854555 |
|
| miR-21 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
24865582 |
|
| miR-1271 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
24875127 |
|
| miR-21 |
Cisplatin |
non-small-cell lung cancer |
Resistant |
Low |
24906642 |
|
| miR-342 |
Cisplatin |
breast cancer |
Sensitive |
Low |
24921394 |
|
| miR-224 |
Cisplatin |
lung adenocarcinoma |
Resistant |
Low |
24921914 |
|
| miR-503 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
24931256 |
|
| miR-182 |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
25012722 |
|
| let-7f-1 |
Cisplatin |
medulloblastoma |
Resistant |
Low |
25014664 |
|
| miR-224 |
Cisplatin |
ovarian papillary serous carcinoma |
Resistant |
Low |
25017423 |
|
| miR-34a |
Cisplatin |
lung cancer |
Associated |
Low |
25038915 |
|
| miR-370 |
Cisplatin |
endometrioid ovarian cancer |
Sensitive |
Low |
25063739 |
|
| miR-551b |
Cisplatin |
lung cancer |
Associated |
Low |
25085901 |
|
| miR-502 |
Cisplatin |
ovarian cancer |
Associated |
Low |
25103640 |
|
| miR-101 |
Cisplatin |
bladder cancer |
Sensitive |
Low |
25109742 |
|
| miR-520f |
Cisplatin |
neuroblastoma |
Resistant |
Low |
25137037 |
|
| miR-136 |
Cisplatin |
glioma |
Sensitive |
Low |
25139024 |
|
| miR-130b |
Cisplatin |
ovarian cancer |
Resistant |
Low |
25155039 |
|
| miR-218 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
25170221 |
|
| miR-29b-1 |
Cisplatin |
osteosarcoma |
Sensitive |
Low |
25174983 |
|
| miR-449a |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
25179844 |
|
| miR-200c |
Cisplatin |
colorectal cancer |
Sensitive |
Low |
25205654 |
|
| miR-638 |
Cisplatin |
triple-negative breast cancer |
Sensitive |
Low |
25228385 |
|
| miR-217 |
Cisplatin |
lung cancer |
Sensitive |
Low |
25234467 |
|
| miR-128 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
25248111 |
|
| miR-101 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
25260883 |
|
| miR-150 |
Cisplatin |
bladder cancer |
Resistant |
Low |
25287716 |
|
| miR-204 |
Cisplatin |
colorectal cancer |
Sensitive |
Low |
25294901 |
|
| miR-21 |
Cisplatin |
lung cancer |
Resistant |
Low |
25323306 |
|
| miR-106a |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
25339370 |
|
| miR-100 |
Cisplatin |
pancreatic cancer |
Sensitive |
Low |
25344675 |
|
| miR-382 |
Cisplatin |
osteosarcoma |
Sensitive |
Low |
25344865 |
|
| let-7a |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| let-7e |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-125a |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-130a |
Cisplatin |
esophageal squamous cell carcinoma |
Resistant |
High |
25356050 |
|
| miR-181a |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-181b |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-18a |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-191 |
Cisplatin |
esophageal adenocarcinoma |
Resistant |
High |
25356050 |
|
| miR-193b |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-200a |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-200b |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-203a |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-23a |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-25 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-296 |
Cisplatin |
esophageal adenocarcinoma |
Resistant |
High |
25356050 |
|
| miR-31 |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-320a |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-320b |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-320c |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-339 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-455 |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-532 |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
High |
25356050 |
|
| miR-638 |
Cisplatin |
esophageal adenocarcinoma |
Resistant |
High |
25356050 |
|
| miR-663a |
Cisplatin |
esophageal adenocarcinoma |
Resistant |
High |
25356050 |
|
| miR-744 |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-92a |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-92b |
Cisplatin |
esophageal adenocarcinoma |
Resistant |
High |
25356050 |
|
| miR-99b |
Cisplatin |
esophageal squamous cell carcinoma |
Sensitive |
High |
25356050 |
|
| miR-21 |
Cisplatin |
osteosarcoma |
Resistant |
Low |
25381586 |
|
| miR-125a |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-129 |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-15a |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-181b |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-182 |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-185 |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-200b |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-205 |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-214 |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-218 |
Cisplatin |
breast cancer |
Sensitive |
Low |
25394901 |
|
| miR-222 |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-302c |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-30c |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-331 |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-33a |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-374b |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-375 |
Cisplatin |
breast cancer |
Sensitive |
High |
25394901 |
|
| miR-663 |
Cisplatin |
breast cancer |
Resistant |
High |
25394901 |
|
| miR-107 |
Cisplatin |
non small cell lung cancer |
Sensitive |
Low |
25400821 |
|
| miR-363 |
Cisplatin |
breast cancer |
Sensitive |
Low |
25416050 |
|
| miR-25 |
Cisplatin |
non-small cell lung cancer |
Resistant |
Low |
25432132 |
|
| miR-96 |
Cisplatin |
esophageal cancer |
Resistant |
Low |
25465153 |
|
| miR-222 |
Cisplatin |
oral squamous cell carcinoma |
Resistant |
Low |
25474084 |
|
| miR-136 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
25482209 |
|
| miR-143 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
25492481 |
|
| miR-23a |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
Low |
25501015 |
|
| miR-21 |
Cisplatin |
oral squamous cell carcinoma |
Associated |
Low |
25514838 |
|
| miR-193a |
Cisplatin |
bladder cancer |
Resistant |
Low |
25542424 |
|
| miR-145 |
Cisplatin |
esophageal adenocarcinoma |
Sensitive |
Low |
25551563 |
|
| miR-145 |
Cisplatin |
esophageal adenocarcinoma |
Resistant |
Low |
25551563 |
|
| miR-340 |
Cisplatin |
hepatocellular carcinoma |
Sensitive |
Low |
25556489 |
|
| miR-21 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
25579119 |
|
| miR-10a |
Cisplatin |
lung cancer |
Resistant |
Low |
25586740 |
|
| miR-23a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
25613625 |
|
| miR-27a |
Cisplatin |
bladder cancer |
Sensitive |
Low |
25656571 |
|
| miR-27b |
Cisplatin |
kidney cancer |
Sensitive |
Low |
25698578 |
|
| miR-27b |
Cisplatin |
liver cancer |
Sensitive |
Low |
25698578 |
|
| miR-93 |
Cisplatin |
ovarian cancer stem cells |
Sensitive |
Low |
25831546 |
|
| miR-483 |
Cisplatin |
tongue squamous cell carcinoma |
Resistant |
Low |
25843291 |
|
| miR-145 |
Cisplatin |
primary epithelial ovarian cancer |
Sensitive |
Low |
25846738 |
|
| miR-429 |
Cisplatin |
primary epithelial ovarian cancer |
Sensitive |
Low |
25846738 |
|
| miR-9 |
Cisplatin |
primary epithelial ovarian cancer |
Sensitive |
Low |
25846738 |
|
| hsa-3149 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| let-7g |
Cisplatin |
ovarian cancer |
Sensitive |
High |
25872328 |
|
| let-7i |
Cisplatin |
ovarian cancer |
Sensitive |
High |
25872328 |
|
| miR-1290 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-141 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-149 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-195 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-1973 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-200c |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-3135a |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-3621 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-3687 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-491 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-636 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miR-933 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
25872328 |
|
| miR-96 |
Cisplatin |
ovarian cancer |
Resistant |
High |
25872328 |
|
| miRPlus-G1246-3p |
Cisplatin |
ovarian cancer |
Sensitive |
High |
25872328 |
|
| miR-7 |
Cisplatin |
small cell lung cancer |
Sensitive |
Low |
25880778 |
|
| miR-101 |
Cisplatin |
squamous cell carcinoma |
Resistant |
Low |
25910754 |
|
| miR-128 |
Cisplatin |
prostate cancer |
Sensitive |
Low |
25921099 |
|
| miR-148b |
Cisplatin |
non-small cell cancer |
Resistant |
Low |
25927928 |
|
| miR-155 |
Cisplatin |
neuroblastoma |
Resistant |
Low |
25972604 |
|
| miR-506 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
25995442 |
|
| miR-23b |
Cisplatin |
gastric cancer |
Sensitive |
Low |
25996293 |
|
| miR-125a |
Cisplatin |
nasopharyngeal carcinoma |
Resistant |
Low |
26017674 |
|
| miR-125b |
Cisplatin |
nasopharyngeal carcinoma |
Resistant |
Low |
26017674 |
|
| miR-107 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-16 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-19b |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-223 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-25 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-27a |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-27b |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-373 |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-378b |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-411 |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-449c |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-451 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-490 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-519b |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-520e |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-598 |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| miR-648 |
Cisplatin |
esophageal cancer |
Sensitive |
High |
26026166 |
|
| miR-875 |
Cisplatin |
esophageal cancer |
Resistant |
High |
26026166 |
|
| let-7d |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| let-7f |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-1258 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-128 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-1297 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-130a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
26043084 |
|
| miR-1321 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26043084 |
|
| miR-146a |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
26043084 |
|
| miR-146b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26043084 |
|
| miR-155 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26043084 |
|
| miR-181a |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26043084 |
|
| miR-182 |
Cisplatin |
ovarian cancer |
Resistant |
Low |
26043084 |
|
| miR-183 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-196a |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-200c |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-21 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26043084 |
|
| miR-25 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-27a |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-31 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-3175 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-365 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-374a |
Cisplatin |
ovarian cancer |
Resistant |
Low |
26043084 |
|
| miR-374b |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26043084 |
|
| miR-374c |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-378b |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-378c |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-4289 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-4297 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26043084 |
|
| miR-590 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-9 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-98 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26043084 |
|
| miR-363 |
Cisplatin |
hepatocellular carcinoma |
Sensitive |
Low |
26143754 |
|
| miR-133a |
Cisplatin |
hepatocellular carcinoma |
Sensitive |
Low |
26239225 |
|
| miR-326 |
Cisplatin |
hepatocellular carcinoma |
Sensitive |
Low |
26239225 |
|
| miR-141 |
Cisplatin |
ovarian cancer |
Sensitive |
High |
26261572 |
|
| miR-18b |
Cisplatin |
ovarian cancer |
Resistant |
High |
26261572 |
|
| miR-199a |
Cisplatin |
ovarian cancer |
Resistant |
High |
26261572 |
|
| miR-199b |
Cisplatin |
ovarian cancer |
Resistant |
High |
26261572 |
|
| miR-215 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26261572 |
|
| miR-335 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26261572 |
|
| miR-363 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26261572 |
|
| miR-645 |
Cisplatin |
ovarian cancer |
Resistant |
High |
26261572 |
|
| miR-10b |
Cisplatin |
glioma |
Resistant |
High |
26323558 |
|
| miR-10b |
Cisplatin |
glioma |
Resistant |
High |
26323558 |
|
| miR-128 |
Cisplatin |
glioma |
Sensitive |
High |
26323558 |
|
| miR-128 |
Cisplatin |
glioma |
Sensitive |
High |
26323558 |
|
| miR-129 |
Cisplatin |
glioma |
Sensitive |
High |
26323558 |
|
| miR-129 |
Cisplatin |
glioma |
Sensitive |
High |
26323558 |
|
| miR-139 |
Cisplatin |
glioma |
Sensitive |
High |
26323558 |
|
| miR-139 |
Cisplatin |
glioma |
Sensitive |
High |
26323558 |
|
| miR-21 |
Cisplatin |
glioma |
Resistant |
High |
26323558 |
|
| miR-21 |
Cisplatin |
glioma |
Resistant |
High |
26323558 |
|
| miR-873 |
Cisplatin |
glioma |
Sensitive |
Low |
26323558 |
|
| miR-181a |
Cisplatin |
lung adenocarcinoma |
Associated |
Low |
26323677 |
|
| miR-196a |
Cisplatin |
non-small-cell lung cancer |
Resistant |
Low |
26376998 |
|
| miR-133b |
Cisplatin |
ovarian carcinoma |
Sensitive |
Low |
26396496 |
|
| miR-134 |
Cisplatin |
breast cancer |
Sensitive |
Low |
26416415 |
|
| miR-26a |
Cisplatin |
gastric cancer |
Sensitive |
Low |
26458859 |
|
| miR-26a |
Cisplatin |
non-small cell lung cancer |
Sensitive |
Low |
26492332 |
|
| miR-7 |
Cisplatin |
lung cancer |
Resistant |
Low |
26542803 |
|
| miR-23a |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
26550261 |
|
| miR-144 |
Cisplatin |
prostate cancer |
Sensitive |
Low |
26566625 |
|
| miR-101 |
Cisplatin |
gastric cancer |
Sensitive |
Low |
26573417 |
|
| miR-634 |
Cisplatin |
bladder cancer |
Sensitive |
Low |
26576679 |
|
| miR-634 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
26576679 |
|
| miR-181a |
Cisplatin |
gastric cancer |
Sensitive |
Low |
26589846 |
|
| miR-100 |
Cisplatin |
ovarian cancer |
Sensitive |
Low |
26607088 |
|
| let-7g |
Cisplatin |
esophageal carcinoma |
Sensitive |
Low |
26655271 |
|
| let-7i |
Cisplatin |
esophageal carcinoma |
Sensitive |
Low |
26655271 |
|
| miR-30a |
Cisplatin |
ovarian carcinoma |
Sensitive |
Low |
26675258 |
|
| miR-100 |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-10a |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-125b |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-1307 |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-181a-2 |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-204 |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-21 |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-222 |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-224 |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-23a |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-27b |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-29a |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-320a |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-320b |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-423 |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-452 |
Cisplatin |
small cell lung cancer |
Sensitive |
High |
26676926 |
|
| miR-7 |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-92a-1 |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|
| miR-92b |
Cisplatin |
small cell lung cancer |
Resistant |
High |
26676926 |
|